These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1130915)

  • 61. [Urinary excretion of dopamine in essential hypertension].
    Fogari R; Marchesi E; Corradi L
    Boll Soc Ital Biol Sper; 1977 Jan; 53(1-2):112-7. PubMed ID: 911469
    [No Abstract]   [Full Text] [Related]  

  • 62. Biochemical changes associated with drug-produced alterations in motor function and the psyche: a possible underlying mechanism.
    Messiha FS; Larson JW
    Proc West Pharmacol Soc; 1977; 20():297-301. PubMed ID: 896838
    [No Abstract]   [Full Text] [Related]  

  • 63. Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
    Kochar MS; Itskovitz HD; Sasse EA; Baker JD; Doumas BT
    J Clin Pharmacol; 1974; 14(8):448-54. PubMed ID: 4851433
    [No Abstract]   [Full Text] [Related]  

  • 64. [Urinary excretion of catecholamines in hypertension and its complications].
    Berezkin SE; Tarasov AN
    Klin Med (Mosk); 1978 Oct; 56(10):48-53. PubMed ID: 713459
    [No Abstract]   [Full Text] [Related]  

  • 65. Urinary excretion of dopamine and homovanillic acid in acute myocardial infarction.
    Januszewicz W; Sznajderman M; Wocial B; Preibisz J; Poplawska W
    Clin Chim Acta; 1971 Apr; 32(2):261-4. PubMed ID: 5122226
    [No Abstract]   [Full Text] [Related]  

  • 66. Cereal ingestion and catecholamine excretion.
    Hoeldtke RD; Wurtman RJ
    Metabolism; 1974 Jan; 23(1):33-41. PubMed ID: 4859598
    [No Abstract]   [Full Text] [Related]  

  • 67. [Urinary excretion of dopamine, noradrenaline and adrenaline in patients with heart failures of various severity].
    Lang R; Dobner P; Meurer KA; Kaufmann W
    Verh Dtsch Ges Inn Med; 1978; (84):673-6. PubMed ID: 33507
    [No Abstract]   [Full Text] [Related]  

  • 68. The excretion of free noradrenaline and adrenaline by healthy young subjects and by patients with essential hypertension.
    Nestel PJ; Doyle AE
    Australas Ann Med; 1968 Nov; 17(4):295-9. PubMed ID: 5701920
    [No Abstract]   [Full Text] [Related]  

  • 69. Improved colorimetry of urinary 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid).
    Knight JA; Haymond RE
    Clin Chem; 1977 Nov; 23(11):2007-10. PubMed ID: 912865
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopamine (3-hydroxytyramine) metabolism in parkinsonism.
    Goodall M; Alton H
    J Clin Invest; 1969 Dec; 48(12):2300-8. PubMed ID: 5355341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of dopamine and homovanillic acid excretion, as prognostic indicators in malignant phaeochromocytoma.
    Tippett PA; West RS; McEwan AJ; Middleton JE; Ackery DM
    Clin Chim Acta; 1987 Jul; 166(2-3):123-33. PubMed ID: 3621593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary excretion of free noradrenaline and adrenaline related to age, sex and hypertension in 265 individuals.
    Lehmann M; Keul J
    Eur J Appl Physiol Occup Physiol; 1986; 55(1):14-8. PubMed ID: 3698984
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angiotensin I and urinary catecholamine excretion in essential hypertension.
    Djurić DS; Manojlović D; Popović V; Subotić Z
    Endokrynol Pol; 1979; 30(3):249-56. PubMed ID: 467389
    [No Abstract]   [Full Text] [Related]  

  • 74. Relationship between urinary excretion of homovanillic acid and norepinephrine metabolites in normal subjects and patients with orthostatic hypotension.
    Kopin IJ; Oliver JA; Polinsky RJ
    Life Sci; 1988; 43(2):125-31. PubMed ID: 3393060
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decreased noradrenaline (norepinephrine) synthesis in familial dysautonomia.
    Goodall MC; Gitlow SE; Alton H
    J Clin Invest; 1971 Dec; 50(12):2734-40. PubMed ID: 5129321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metabolic and hormonal studies in patients with essential hypertension.
    Januszewicz W; Ciswicka-Sznajderman M; Wocial B; Sznajderman M; Ignatowska-Switalska H; Berent H; Zukowska-Grojec Z; Feltynowski T
    Br Heart J; 1977 Nov; 39(11):1205-9. PubMed ID: 588376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The heterogeneity of dopamine involvement in essential hypertension.
    Kuchel O
    Clin Exp Hypertens A; 1989; 11 Suppl 1():217-25. PubMed ID: 2663248
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of 3,4-dimethoxyphenylethylamine injections upon dopamine metabolism in rats and dogs.
    Barbeau A; Lescop J; Duplessis P; Elie R
    Experientia; 1967 Jul; 23(7):536-8. PubMed ID: 6057737
    [No Abstract]   [Full Text] [Related]  

  • 79. [Adrenaline excretion and cardiovascular complications in patients with essential hypertension].
    Januszewicz W; Wocial B; Sznajderman M; Feltynowski T
    Pol Tyg Lek; 1977 Feb; 32(9):349-51. PubMed ID: 840761
    [No Abstract]   [Full Text] [Related]  

  • 80. Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.
    Evers LJ; Curfs LM; Bakker JA; Boot E; da Silva Alves F; Abeling N; Bierau J; Drukker M; van Amelsvoort TA
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1159-65. PubMed ID: 24713114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.